Displaying 1 - 3 of 3
| Active Ingredient | GENTAMICIN |
| Therapeutic Class | AMINOGLYCOSIDES |
| Indications | Septicaemia and neonatal sepsis, biliary infections, intraabdominal and UTI, acute pyelonephritis. Severe gram-negative infections, primarily pseudomonas infections. |
| Caution | Increase dose interval in renal impairment in children and the elderly. Use nomogram (see renal disease guidelines p.19-38) and check peak (1 hour) and trough (predose) levels. Nehrotoxicity or ototo More ... |
| Dose Range |
i.m. 3-5mg/kg/day in divided doses every 8 hours for 7-10 days. 12 hours (clearance 30-70 ml/min), 24 hours (clearance 10-30ml/min, 48 hours (clearance 5-10ml/min) |
| Drug Interactions | |
| Pregnancy | Risk of auditory or vestibular nerve damage in the infant when aminoglycosides a More ... |
| Breast Feeding |
| Active Ingredient | GENTAMICIN |
| Therapeutic Class | EENT ANTIBACTERIALS |
| Indications |
Septicaemia and neonatal sepsis, biliary infections, intraabdominal and UTI, acute p y elonep hritis. Severegram-negative infections, primarily pseudomonas infections. |
| Caution | Increase dose interval in renal imp airment in children and the elderly . Use nomogram (see renal disease guidelines p . 19-38) and check p eak (1 hour) and trough (p re dose) levels. Ne hrotoxicity More ... |
| Dose Range |
i.m. 3-5mg/kg/day in divided doses every 8 hours for 7-10 day s. 12 hours (clearance 30-70 ml/min), 24 hours (clearance 10-30ml/min, 48 hours (clearance 5-10ml/min) |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | GENTAMICIN |
| Therapeutic Class | ANTIBIOTICS TOPICAL |
| Indications | Skin infections. |
| Caution |
Apply ointment sparingly to affected areas. When possible, Sensitivity of the organism should be determined before treatment as resistant organisms are common. Sensitisation may occur. |
| Dose Range |
Apply 3 times daily to infected areas. See BDS supply protocols pg. 6. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |